GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroGen Inc (MEX:FGEN) » Definitions » E10

FibroGen (MEX:FGEN) E10 : MXN-56.46 (As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is FibroGen E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

FibroGen's adjusted earnings per share data for the three months ended in Jun. 2024 was MXN-2.931. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is MXN-56.46 for the trailing ten years ended in Jun. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-09-26), FibroGen's current stock price is MXN7.50. FibroGen's E10 for the quarter that ended in Jun. 2024 was MXN-56.46. FibroGen's Shiller PE Ratio of today is .


FibroGen E10 Historical Data

The historical data trend for FibroGen's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroGen E10 Chart

FibroGen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -33.15 -37.09

FibroGen Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -255.27 -38.62 -37.09 -32.91 -56.46

Competitive Comparison of FibroGen's E10

For the Biotechnology subindustry, FibroGen's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


FibroGen's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, FibroGen's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where FibroGen's Shiller PE Ratio falls into.



FibroGen E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, FibroGen's adjusted earnings per share data for the three months ended in Jun. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=-2.931/132.5538*132.5538
=-2.931

Current CPI (Jun. 2024) = 132.5538.

FibroGen Quarterly Data

per share eps CPI Adj_EPS
201409 -9.535 100.428 -12.585
201412 -12.630 99.070 -16.899
201503 -11.891 99.621 -15.822
201506 13.023 100.684 17.145
201509 -12.505 100.392 -16.511
201512 -14.616 99.792 -19.414
201603 -7.746 100.470 -10.220
201606 6.473 101.688 8.438
201609 -7.347 101.861 -9.561
201612 -10.102 101.863 -13.146
201703 -9.038 102.862 -11.647
201706 -8.315 103.349 -10.665
201709 -5.807 104.136 -7.392
201712 -5.303 104.011 -6.758
201803 -9.084 105.290 -11.436
201806 -5.502 106.317 -6.860
201809 -9.352 106.507 -11.639
201812 4.516 105.998 5.647
201903 -10.281 107.251 -12.707
201906 24.203 108.070 29.686
201909 -11.253 108.329 -13.769
201912 -21.123 108.420 -25.825
202003 -20.869 108.902 -25.402
202006 -21.928 108.767 -26.723
202009 7.732 109.815 9.333
202012 -12.731 109.897 -15.356
202103 -15.944 111.754 -18.911
202106 -28.864 114.631 -33.377
202109 11.103 115.734 12.717
202112 -29.745 117.630 -33.519
202203 -13.539 121.301 -14.795
202206 -15.692 125.017 -16.638
202209 -19.713 125.227 -20.866
202212 -13.647 125.222 -14.446
202303 -14.600 127.348 -15.197
202306 -15.430 128.729 -15.888
202309 -11.322 129.860 -11.557
202312 -9.675 129.419 -9.909
202403 -5.477 131.776 -5.509
202406 -2.931 132.554 -2.931

Add all the adjusted EPS together and divide 10 will get our e10.


FibroGen  (MEX:FGEN) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


FibroGen E10 Related Terms

Thank you for viewing the detailed overview of FibroGen's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


FibroGen Business Description

Traded in Other Exchanges
Address
409 Illinois Street, San Francisco, CA, USA, 94158
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

FibroGen Headlines

From GuruFocus

PRIMECAP Management Adjusts Position in FibroGen Inc

By GuruFocus Research 02-13-2024

Q4 2021 FibroGen Inc Earnings Call Transcript

By GuruFocus Research 02-07-2024

Q1 2023 FibroGen Inc Earnings Call Transcript

By GuruFocus Research 02-07-2024

Q4 2022 FibroGen Inc Earnings Call Transcript

By GuruFocus Research 02-07-2024

Q1 2022 FibroGen Inc Earnings Call Transcript

By GuruFocus Research 02-07-2024

Q3 2023 FibroGen Inc Earnings Call Transcript

By GuruFocus Research 02-07-2024